Anthony Leonardi
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
- Oncology 4
- CAR-T cell therapy research 3
- Co-authors
- Nicholas P. Restifo (3 shared papers)Richard A. Morgan (2 shared papers)Steven A. Rosenberg (2 shared papers)Sid P. Kerkar (2 shared papers)Zhiya Yu (2 shared papers)Ena Wang (1 shared paper)Dhanalakshmi Chinnasamy (1 shared paper)Giorgio Trinchieri (1 shared paper)
- Journals
- Pathogens (2 papers)Frontiers in Immunology (2 papers)Molecular Therapy (1 paper)Frontiers in Public Health (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Anthony Leonardi
10 papers receiving 511 citations
Peers
Comparison fields: 5 of 67
- Immunology 292
- Oncology 377
- Genetics 108
- Biotechnology 20
- Molecular Biology 139
Countries citing papers authored by Anthony Leonardi
This map shows the geographic impact of Anthony Leonardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Leonardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Leonardi more than expected).
Fields of papers citing papers by Anthony Leonardi
This network shows the impact of papers produced by Anthony Leonardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Leonardi. The network helps show where Anthony Leonardi may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Leonardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 262 | |
| 2 | 2017 | 160 | |
| 3 | 2013 | 48 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 14 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 3 | |
| 8 | [Rapid method for quantitative evaluation of cytotoxic activity in tissue culture by electronic cell counting]. | 1966 | 2 |
| 9 | 2022 | 1 | |
| 10 | 2024 | 1 |
About Anthony Leonardi
Anthony Leonardi is a scholar working on Infectious Diseases, Oncology, Immunology, Molecular Biology and Neurology, having authored 10 papers that have together received 518 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (2 papers), Infection Control and Ventilation (1 paper), Long-Term Effects of COVID-19 (1 paper) and Immune responses and vaccinations (1 paper). The work is most often cited by research in Immunology (292 citations), Oncology (377 citations), Genetics (108 citations), Biotechnology (20 citations) and Molecular Biology (139 citations). Anthony Leonardi has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Nicholas P. Restifo, Richard A. Morgan, Steven A. Rosenberg, Sid P. Kerkar, Zhiya Yu, Ena Wang, Dhanalakshmi Chinnasamy, Giorgio Trinchieri, Romina S. Goldszmid and Francesco M. Marincola. Their work appears in journals such as Pathogens, Frontiers in Immunology, Molecular Therapy, Frontiers in Public Health and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.